檢索結果 - Rodabe N Amaria
- Showing 1 - 7 results of 7
-
1
-
2
Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients 由 Michael T. Tetzlaff, Kelly C. Nelson, Adi Diab, Gregg A. Staerkel, Priyadharsini Nagarajan, Carlos A. Torres-Cabala, Beth A. Chasen, Jennifer A. Wargo, Victor G. Prieto, Rodabe N. Amaria, Jonathan L. Curry
發表在 Journal for ImmunoTherapy of Cancer (2018-02-01)獲取全文
Article -
3
Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma 由 Sydney A. Keatts, Aya F. Salem, David M. Swanson, Ahsan S. Farooqi, Andrew J. Bishop, Rodabe N. Amaria, Jennifer L. McQuade, Isabella C. Glitza Oliva, Adi Diab, Roi Weiser, Sarah B. Fisher, Ryan P. Goepfert, Merrick I. Ross, B. Ashleigh Guadagnolo, Devarati Mitra
發表在 Clinical and Translational Radiation Oncology (2024-11-01)獲取全文
Article -
4
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic... 由 Sapna Patel, Adi Diab, Michael A. Davies, Jennifer L. McQuade, Michael K. Wong, Isabella C. Glitza, Hussein A. Tawbi, Rodabe N. Amaria, Chantal Saberian, Enrique Alvarez, Amer M. Najjar, Laszlo G. Radvanyi, Cara L. Haymaker, Roland L. Bassett, Silvana C. Faria, Sapna Parshottam, Victor Prieto, Elizabeth J. Shpall
發表在 Journal for ImmunoTherapy of Cancer (2021-05-01)獲取全文
Article -
5
Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma 由 Merve Hasanov, Simin Kiany, Marie-Andrée Forget, Roland Bassett, Michael A. Davies, Adi Diab, Jeffrey E. Gershenwald, Isabella C. Glitza, Jeffrey E. Lee, Anthony Lucci, Jennifer L. McQuade, Sapna P. Patel, Merrick I. Ross, Hussein A. Tawbi, Jennifer A. Wargo, Michael K. Wong, Chantale Bernatchez, Patrick Hwu, Cara Haymaker, Rodabe N. Amaria
發表在 OncoImmunology (2025-12-01)獲取全文
Article -
6
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma 由 Joel Ho, Jane Mattei, Michael Tetzlaff, Michelle D. Williams, Michael A. Davies, Adi Diab, Isabella C. Glitza Oliva, Jennifer McQuade, Sapna P. Patel, Hussein Tawbi, Michael K. Wong, Sarah B. Fisher, Ehab Hanna, Emily Z. Keung, Merrick Ross, Roi Weiser, Shirley Y. Su, Michael Frumovitz, Larissa A. Meyer, Amir Jazaeri, Curtis A. Pettaway, B. Ashleigh Guadagnolo, Andrew J. Bishop, Devarati Mitra, Ahsan Farooqi, Roland Bassett, Silvana Faria, Priyadharsini Nagarajan, Rodabe N. Amaria
發表在 Frontiers in Oncology (2022-10-01)獲取全文
Article -
7
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma 由 Sydney Ch’ng, María González, Ines Pires da Silva, Rodabe N Amaria, Li Zhou, Shahneen Sandhu, Georgina V Long, Zeynep Eroglu, David E Gyorki, Richard A Scolyer, Andrew J Spillane, George Au-Yeung, Elizabeth M Burton, Christian U Blank, Hussein A Tawbi, Robert V Rawson, Alexander M Menzies, Matteo S Carlino, Igor Samoylenko, Serigne N Lo, Robyn P M Saw, Kerwin F Shannon, Alexander C J van Akkooi, Milton Jose Barros e Silva, Edward Hsiao, Thomas E Pennington, Rony Kapoor, João Pedreira Duprat, Rafaela Brito de Paula
發表在 Journal for ImmunoTherapy of Cancer (2025-03-01)獲取全文
Article
